Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG) - solution
A technology of 18F-FDG and glucose, which is applied in the field of obtaining 2-18F-fluoro-2-deoxy-D-glucose (18F-FDG) solution, can solve the problem of limiting the service life of the compound, reducing the radiochemical purity of the compound, incompatibility, etc. question
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0013] Embodiment 1: at pH4.5-5.5 to 18 F-FDG solution is autoclaved
[0014] 3 experimental rounds were conducted to study the use of weakly acid-buffered 18 Radiochemical purity of F-fluoro-2-deoxy-glucose (FDG) solutions compared to unbuffered solutions in saline.
[0015] After production, dilute with salt water 18 F-fluoro-deoxy-glucose (FDG) solution to a radioactivity concentration of 3 mCi / ml at ART (Activity Refeence Time) (t=0). After 2 hours of production, 0.5 ml of 18 A vial of F-fluoro-deoxy-glucose (FDG) solution, mixed with 0.1 ml of buffer (10 mM), was then autoclaved.
[0016] Table 1 shows the different buffered 18 Radiochemical purity of F-fluoro-deoxy-glucose (FDG) solutions after autoclaving at 134 °C for 5 min. Using KAVO Sterimaster TM Directly after autoclaving.
[0017] Table 1
[0018] 18 Radiochemical purity of F-FDG (%)
[0019] All test buffers achieved high radiochemical purity relative to the unbuffered reference sample N...
Embodiment 2
[0020] Example 2: Low pH range (pH2-3) 18 Autoclaving of F-FDG solution
[0021] 2 rounds of experiments were conducted to study the use of weak acid buffered to pH 2-3 18 Radiochemical purity of F-fluoro-deoxy-glucose (FDG) solutions.
[0022] with salt water 18 F-fluoro-deoxy-glucose (FDG) solutions were diluted directly after production to a radiochemical purity of 3 mCi / ml at ART (12:00h). After 2 hours of production, 0.5 ml of 18 A vial of F-fluoro-deoxy-glucose (FDG) solution mixed with 0.1 ml of buffer (100 mM) was then autoclaved.
[0023] buffer
[0024] All test buffers exhibited high radiochemical purity compared to the unbuffered reference sample NaCl / pH 6.2. A 2-3% reduction was observed with weakly acid buffered samples compared to the control sample (9% reduction in radiochemical purity). For all buffers (ascorbic acid, citric acid, acetic acid), there was no significant reduction in radiochemical purity compared to non-autoclaved samples (Table ...
Embodiment 3
[0025] Example 3: 18 Radiation decomposition of F-FDG
[0026] Measured over a period of approximately 8.5 hours 18 Radioactivity concentration of F-FDG. The radioactivity concentration at ART (t=0) was 3 mCi / ml.
[0027] 2 buffers were tested and compared to a reference sample in 0.9% NaCl / pH 6.9. The first buffer is citrate buffer pH 4.5 and the second buffer is ascorbic acid buffer pH 4.5. Five determinations of the radiochemical purity of the samples were performed in intervals. The results are shown in Table 3.
[0028] buffer / pH
[0029] Radiolysis was reduced in both test buffers compared to the 0.9% NaCl sample. The greatest reduction was observed when using ascorbic acid buffer. After 8.5 hours there was only a 2% loss of activity. 4% and 6% for citrate buffer and 0.9% NaCl, respectively. It was concluded that after adding ascorbic acid or citrate buffer, compared with no buffer, 18 F-FDG is more stable.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com